Pfizer Inc. Hints At Potential Hostile Move For AstraZeneca PLC

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Pfizer Inc's top officials said on Monday they are weighing all strategies, including potential hostile maneuvers, in the company's effort to seal a $106 billion takeover of British drugmaker AstraZeneca Plc.

"Any option you can think of would be an option," Pfizer Chief Financial Officer Frank D'Amelio said in a telephone interview, when asked whether Pfizer might take its case directly to AstraZeneca shareholders before a May 26 deadline.

Help employers find you! Check out all the jobs and post your resume.

Back to news